For the quarter ending 2025-09-30, SSKN made $6,929K in revenue. -$1,622K in net income. Net profit margin of -23.41%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenues, net | 6,929 | 7,663 | 6,812 | 8,165 |
| Cost of revenues | 2,745 | 3,357 | 3,165 | 3,747 |
| Gross profit | 4,184 | 4,306 | 3,647 | 4,419 |
| Engineering and product development | 172 | 86 | 96 | 221 |
| Impairment of goodwill | - | - | - | 965 |
| Selling and marketing | 3,201 | 3,533 | 2,993 | 3,114 |
| General and administrative | 2,668 | 2,911 | 2,573 | 3,678 |
| Settlement gains | 684 | - | - | - |
| Total operating expenses | 5,357 | 6,530 | 5,662 | 7,977 |
| Loss from operations | -1,173 | -2,224 | -2,015 | -3,558 |
| Interest expense | 498 | 491 | 486 | 1,973 |
| Interest income | 49 | 226 | 69 | 60 |
| Other income | 0 | 0 | - | 0 |
| Total other expense | -449 | -265 | -417 | 994 |
| Loss before benefit from income taxes | - | - | - | -2,564 |
| Benefit from income taxes | - | - | - | -42 |
| Net loss | -1,622 | -2,489 | -2,432 | -3,932 |
| Net loss per share of common stock - basic (in dollars per share) | -0.36 | -0.6 | -0.58 | -1.045 |
| Net loss per share of common stock - diluted (in dollars per share) | -0.36 | -0.6 | -0.58 | -1.045 |
| Weighted average shares of common stock outstanding - basic (in shares) | 4,481,337 | 4,171,161 | 4,171,161 | -1,868,913.5 |
| Weighted average shares of common stock outstanding - diluted (in shares) | 4,481,337 | 4,171,161 | 4,171,161 | -1,868,913.5 |
STRATA Skin Sciences, Inc. (SSKN)
STRATA Skin Sciences, Inc. (SSKN)